Dermoneen
- Manufacturer
- Phillips Company
- Effective date
- 2011-01-06
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-05-31 22:27:05
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
DRUG FACTS
Active Ingredient Purpose
Salicylic acid (2%) Psoriasis medication
______________________________________
Uses
n Controls the symptoms of psoriasis.
______________________________________
Warnings
n For external use only
n When using this product, skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time.
n Keep away from children
n Avoid contact with the eyes. If contact occurs, rinse eyes thoroughly with water.
n May be harmful if swallowed or inhaled
______________________________________
Ask a physician
n If symptoms last for more than 7 days or clear up and recur within a few days.
n If the conditions do not improve.
n Before use on children under 2 years.
n Before use if you are allergic to any ingredients listed on this label.
n If condition worsens or does not improve after regular use of this product as directed, consult a physician.
n If condition covers a large area of the body, consult your physician before using this product.
______________________________________
Directions
n Clean the skin thoroughly before applying this product.
n Apply product sparingly to one or two small affected areas during the first 3 days. If no discomfort occurs, follow the directions stated below.
n Apply to affected areas one times daily or as directed by a physician. Each morning, cover the entire affected area with a thin layer of this product. Apply this product by rubbing it in. If any liquid remains on the skin (after a 20-second rub-in), you have applied too much product.
______________________________________
Other information
Store at 40 to 100 degrees F. Net contents: 3 mL. This product contains no alcohol; no animal products.
______________________________________
Inactive ingredients
Water, dimethyl sulfoxide, dipropylene glycol, ascorbic acid, sorbic acid, magnesium stearate, stearic acid.
______________________________________
Questions and Side effects
Use of this product results in no known side effects when used according to directions. Phillips Company, 311 Chickasaw Street, Millerton, OK USA 74750; Tel. 580-746-2430
Email address: hp@valliant.net
ACTIVE INGREDIENTS
Active Ingredient Purpose
Salicylic acid (2%) Psoriasis medication
ASK DOCTOR
n If symptoms last for more than 7 days or clear up and recur within a few days.
n If the conditions do not improve.
n Before use on children under 2 years.
n Before use if you are allergic to any ingredients listed on this label.
n If condition worsens or does not improve after regular use of this product as directed, consult a physician.
n If condition covers a large area of the body, consult your physician before using this product.
DO NOT USE
n When using this product, skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time.
n Keep away from children
n Avoid contact with the eyes. If contact occurs, rinse eyes thoroughly with water.
n May be harmful if swallowed or inhaled
n If condition worsens or does not improve after regular use of this product as directed, consult a physician.
n If condition covers a large area of the body, consult your physician before using this product.
CHILDREN
Keep away from children
Avoid contact with eyes
May be harmful if swallowed or inhaled
PURPOSE
Salicylic acid (2%) Psoriasis medication
STOP USE
WHEN USING
n When using this product, skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time.
n Keep away from children
n Avoid contact with the eyes. If contact occurs, rinse eyes thoroughly with water.
n May be harmful if swallowed or inhaled
n Clean the skin thoroughly before applying this product.
n Apply product sparingly to one or two small affected areas during the first 3 days. If no discomfort occurs, follow the directions stated below.
n Apply to affected areas one times daily or as directed by a physician. Each morning, cover the entire affected area with a thin layer of this product. Apply this product by rubbing it in. If any liquid remains on the skin (after a 20-second rub-in), you have applied too much product.
WARNINGS
n For external use only
n When using this product, skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time.
n Keep away from children
n Avoid contact with the eyes. If contact occurs, rinse eyes thoroughly with water.
n May be harmful if swallowed or inhaled
DOSAGE & ADMINISTRATION
n Clean the skin thoroughly before applying this product.
n Apply product sparingly to one or two small affected areas during the first 3 days. If no discomfort occurs, follow the directions stated below.
n Apply to affected areas one times daily or as directed by a physician.
n Each morning, cover the entire affected area with a thin layer of this product. Apply this product by rubbing it in. If any liquid remains on the skin (after a 20-second rub-in), you have applied too much product.
USE
n Controls the symptoms of psoriasis.
Directions
n Clean the skin thoroughly before applying this product.
n Apply product sparingly to one or two small affected areas during the first 3 days. If no discomfort occurs, follow the directions stated below.
n Apply to affected areas one times daily or as directed by a physician.
n Each morning, cover the entire affected area with a thin layer of this product. Apply this product by rubbing it in. If any liquid remains on the skin (after a 20-second rub-in), you have applied too much product.
INACTIVE INGREDIENTS
Water, dimethyl sulfoxide, dipropylene glycol, ascorbic acid, sorbic acid, magnesium stearate, stearic acid.
Image of product
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 1087798 | Dermoneen 2 % Topical Lotion | PSN | 1 |
| 103568 | salicylic acid 2 % Topical Lotion | PSN | 1 |
| 1087798 | salicylic acid 20 MG/ML Topical Lotion [Dermoneen] | SBD | 1 |
| 103568 | salicylic acid 20 MG/ML Topical Lotion | SCD | 1 |
| 1087798 | Dermoneen 2 % Topical Lotion | SY | 1 |
| 1087798 | Dermoneen 20 MG/ML Topical Lotion | SY | 1 |
| 103568 | salicylic acid 2 % Topical Lotion | SY | 1 |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| c5cd4727-ac49-4409-82b1-5bd8006c3ec7 | Product name | 1 | 20171122 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 43074-111-22 | 2019-10-29 | C162847 | 48780-1 | 960f7f55-d50e-8e05-e053-dbdaa90a074a | DRUG FACTS |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 43074-111-21 | Dermoneen | 3 mL in 1 BOTTLE, DROPPER | LOTION | 3 | 1 | |
| 43074-111-22 | Dermoneen | 1 in 1 BOX | LOTION | 1 | 1 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| SALICYLIC ACID | ACTIVE INGREDIENT | O414PZ4LPZ | 1 | |
| SALICYLIC ACID | ACTIVE MOIETY | O414PZ4LPZ | 1 | |
| ascorbic acid | INACTIVE INGREDIENT | PQ6CK8PD0R | 1 | |
| dimethyl sulfoxide | INACTIVE INGREDIENT | YOW8V9698H | 1 | |
| dipropylene glycol | INACTIVE INGREDIENT | E107L85C40 | 1 | |
| magnesium stearate | INACTIVE INGREDIENT | 70097M6I30 | 1 | |
| sorbic acid | INACTIVE INGREDIENT | X045WJ989B | 1 | |
| stearic acid | INACTIVE INGREDIENT | 4ELV7Z65AP | 1 | |
| water | INACTIVE INGREDIENT | 059QF0KO0R | 1 |
Products#
Every source-derived product name is available through these pages.
- Dermoneen
- SALICYLIC ACID
- dimethyl sulfoxide
- ascorbic acid
- dipropylene glycol
- water
- sorbic acid
- magnesium stearate
- stearic acid
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 43074-111 | 43074-111-21, 43074-111-22 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| dimethyl sulfoxide | YOW8V9698H | IACT |
| ascorbic acid | PQ6CK8PD0R | IACT |
| dipropylene glycol | E107L85C40 | IACT |
| water | 059QF0KO0R | IACT |
| sorbic acid | X045WJ989B | IACT |
| magnesium stearate | 70097M6I30 | IACT |
| stearic acid | 4ELV7Z65AP | IACT |
| SALICYLIC ACID | O414PZ4LPZ | ACTIB |
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | WAFER / ORAL | 66 mg | ||
| ascorbic acid | ASCORBIC ACID | PQ6CK8PD0R | SUSPENSION, EXTENDED RELEASE / ORAL | 6 mg | ||
| ascorbic acid | ASCORBIC ACID | PQ6CK8PD0R | CAPSULE, DELAYED RELEASE / ORAL | 12 mg | ||
| ascorbic acid | ASCORBIC ACID | PQ6CK8PD0R | INJECTION, SOLUTION / INFILTRATION | 0.2 %w/v | ||
| ascorbic acid | ASCORBIC ACID | PQ6CK8PD0R | SOLUTION / TOPICAL | 0.04 %w/w | ||
| magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | IMPLANT / INTRAVITREAL | NA | ||
| magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | SUSPENSION, EXTENDED RELEASE / ORAL | 71 mg | ||
| stearic acid | STEARIC ACID | 4ELV7Z65AP | CAPSULE / ORAL | 90 mg | ||
| magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | GRANULE, FOR SUSPENSION / ORAL | 14 mg | ||
| magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | TABLET, SUGAR COATED / ORAL | NA | ||
| magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | SUSPENSION / ORAL | 64 mg | ||
| stearic acid | STEARIC ACID | 4ELV7Z65AP | EMULSION / TOPICAL | NA | ||
| magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | TABLET, DELAYED RELEASE / ORAL | 144 mg | ||
| stearic acid | STEARIC ACID | 4ELV7Z65AP | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 120 mg | ||
| magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | IMPLANT / SUBCUTANEOUS | 0.5 mg | ||
| magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | TABLET, COATED / ORAL | 184 mg | ||
| ascorbic acid | ASCORBIC ACID | PQ6CK8PD0R | CAPSULE, EXTENDED RELEASE / ORAL | 17 mg | ||
| ascorbic acid | ASCORBIC ACID | PQ6CK8PD0R | TABLET, FILM COATED / ORAL | 20 mg | ||
| sorbic acid | SORBIC ACID | X045WJ989B | SOLUTION/ DROPS / OPHTHALMIC | 0.2 %w/v | ||
| magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | TABLET, FOR SUSPENSION / ORAL | 131 mg | ||
| magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | POWDER / ORAL | 25 mg | ||
| dipropylene glycol | DIPROPYLENE GLYCOL | E107L85C40 | SYSTEM / TRANSDERMAL | 6 mg | ||
| sorbic acid | SORBIC ACID | X045WJ989B | GEL / TOPICAL | 2 mg | ||
| stearic acid | STEARIC ACID | 4ELV7Z65AP | TABLET / ORAL | 336 mg | ||
| ascorbic acid | ASCORBIC ACID | PQ6CK8PD0R | SYRUP / ORAL | 200 mg | ||
| magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | TABLET, CHEWABLE, EXTENDED RELEASE / ORAL | 9 mg | ||
| sorbic acid | SORBIC ACID | X045WJ989B | TABLET / SUBLINGUAL | 0.16 mg | ||
| dipropylene glycol | DIPROPYLENE GLYCOL | E107L85C40 | FILM, EXTENDED RELEASE / TRANSDERMAL | 296 mg | ||
| dimethyl sulfoxide | DIMETHYL SULFOXIDE | YOW8V9698H | SOLUTION / TOPICAL | 8008 mg | ||
| magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | POWDER, FOR SUSPENSION / ORAL | 120 mg | ||
| magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | TABLET / SUBLINGUAL | 17.5 mg | ||
| dimethyl sulfoxide | DIMETHYL SULFOXIDE | YOW8V9698H | LOTION / TOPICAL | 45.5 %w/w | ||
| stearic acid | STEARIC ACID | 4ELV7Z65AP | OINTMENT / TOPICAL | 15 %w/w | ||
| stearic acid | STEARIC ACID | 4ELV7Z65AP | PELLET / SUBCUTANEOUS | 0.97 mg | ||
| magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | INSERT / VAGINAL | 69 mg | ||
| stearic acid | STEARIC ACID | 4ELV7Z65AP | SHAMPOO / TOPICAL | 9.7 %w/w | ||
| magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | DROPS / ORAL | NA | ||
| stearic acid | STEARIC ACID | 4ELV7Z65AP | TABLET, DELAYED RELEASE / ORAL | 80 mg | ||
| sorbic acid | SORBIC ACID | X045WJ989B | TABLET / ORAL | 10 mg | ||
| magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | SYSTEM / INTRAVITREAL | 0.02 mg | ||
| magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | TABLET, FILM COATED / ORAL | 96 mg | ||
| ascorbic acid | ASCORBIC ACID | PQ6CK8PD0R | TABLET, ORALLY DISINTEGRATING / ORAL | 2.35 mg | ||
| stearic acid | STEARIC ACID | 4ELV7Z65AP | LOTION / TOPICAL | 80 mg | ||
| magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | TABLET / BUCCAL | 17.5 mg | ||
| magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | POWDER / TOPICAL | 104 mg | ||
| magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | RING / VAGINAL | 2 mg | ||
| sorbic acid | SORBIC ACID | X045WJ989B | CONCENTRATE / ORAL | 1 mg | ||
| magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | POWDER / RESPIRATORY (INHALATION) | 0.13 mg | ||
| sorbic acid | SORBIC ACID | X045WJ989B | SOLUTION / OPHTHALMIC | 0.2 %w/v | ||
| ascorbic acid | ASCORBIC ACID | PQ6CK8PD0R | INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS | 2 mg | ||
| magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 53 mg | ||
| dimethyl sulfoxide | DIMETHYL SULFOXIDE | YOW8V9698H | INJECTION, POWDER, FOR SUSPENSION / INTRAVENOUS | NA | ||
| sorbic acid | SORBIC ACID | X045WJ989B | TABLET, DELAYED RELEASE / ORAL | 0.03 mg | ||
| magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | INHALANT / ORAL | 0.08 mg | ||
| sorbic acid | SORBIC ACID | X045WJ989B | TABLET, FILM COATED / ORAL | 5 mg | ||
| stearic acid | STEARIC ACID | 4ELV7Z65AP | POWDER, FOR SUSPENSION / ORAL | 1203 mg/5ml | ||
| sorbic acid | SORBIC ACID | X045WJ989B | CREAM / TOPICAL | 14 mg | ||
| stearic acid | STEARIC ACID | 4ELV7Z65AP | TABLET / BUCCAL | 6 mg | ||
| magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | CREAM / TOPICAL | NA | ||
| dimethyl sulfoxide | DIMETHYL SULFOXIDE | YOW8V9698H | IMPLANT / SUBCUTANEOUS | 104 mg |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 50d6fcb2-68f1-4fa4-8f50-93b80a53e2e9 | 51b97443-5764-44c9-a2a8-cd1bc01b2c66 | 2011-01-06 | Warnings | 50d6fcb2-68f1-4fa4-8f50-93b80a53e2e9 51b97443-5764-44c9-a2a8-cd1bc01b2c66 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
